Australia's largest stock trading and investment forum Australia's #1 stock forum

OPT

Click for more information

1.27%

78.0¢ opthea limited

Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD, page-46

First 46 Last

Share
Profile

Follow
whytee

17,010 Posts.

2412

13/07/21

19:33

Post #: 54476966
Share

Originally posted by hottod ↑

You can find that information in the Annual Report.

Opthea owns a patent family covering the OPT‑302 molecule, and uses thereof, extending out to February 2034. This patent has been filed in 19 jurisdictions and has already granted in the United States, Europe (validated in 38 countries), Japan, Australia, New Zealand, Malaysia, Singapore, Mexico, South Africa, Colombia and Russia. The patent application has been accepted for grant in Canada and Israel, and is currently pending in China, Brazil, India, South Korea, Indonesia and the Philippines.

The United States patent, which granted in August 2017, includes broad claims to the OPT‑302 molecule, and analogues thereof, and their use to treat disorders involving neovascularisation, including eye diseases such as wet AMD and DME. In the United States, Opthea has another granted patent relating to solubleVEGFR‑3 molecules which includes composition of matter claims to soluble VEGFR‑3 molecules (such as OPT ‑302) and extends out to November 2026.

Expand

However if they get granted patents related to the combination therapy then I think the patent clock may be reset starting in 2023 0r 24...

OPT Price at posting: $1.32 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

LML

Lincoln touts its flagship project as key to state government's Green Iron and Steel future

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 55 more messages in this thread...

First 46 Last

Add OPT (ASX) to my watchlist

(20min delay)
Last 78.0¢		Change -0.010(1.27%)		Mkt cap ! $960.2M

Open	High	Low	Value	Volume
79.0¢	79.5¢	74.5¢	$2.420M	3.109M

Buyers (Bids)

No.	Vol.	Price($)
1	1000	77.0¢

Sellers (Offers)

Price($)	Vol.	No.
78.0¢	77447	1

View Market Depth

No.	Vol.	Price($)
1	1000	0.770
1	900	0.765
3	56490	0.750
2	5791	0.745
3	10831	0.740

Price($)	Vol.	No.
0.795	3768	1
0.800	94863	4
0.810	50000	1
0.820	8300	3
0.825	2500	1

Last trade - 16.10pm 27/09/2024 (20 minute delay)

OPT (ASX) Chart